Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|November 8, 2006
[Case of rapid progressive interstitial pneumonia associated with primary Sjogren syndrome]Yoshihisa Naruse, Naoki Inui, Hideki Yasui, et al.Cancer Chemotherapy and Pharmacology|May 16, 2019
Olanzapine-containing antiemetic therapy for the prevention of carboplatin-induced nausea and vomitingKazuki Tanaka, Naoki Inui, Masato Karayama, et al.Cancer Immunology, Immunotherapy : CII|April 26, 2023
Cytokine profiling identifies circulating IL-6 and IL-15 as prognostic stratifiers in patients with non-small cell lung cancer receiving anti-PD-1/PD-L1 blockade therapyYusuke Inoue, Naoki Inui, Masato Karayama, et al.Respirology (Carlton, Vic.)|April 11, 2008
Possible therapeutic effect of direct haemoperfusion with a polymyxin B immobilized fibre column (PMX-DHP) on pulmonary oxygenation in acute exacerbations of interstitial pneumoniaNoriyuki Enomoto, Takafumi Suda, Tomohiro Uto, et al.Investigational New Drugs|August 18, 2020
Erlotinib and bevacizumab in elderly patients ≥75 years old with non-small cell lung cancer harboring epidermal growth factor receptor mutationsYoichiro Aoshima, Masato Karayama, Naoki Inui, et al.Investigational New Drugs|February 22, 2019
Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinomaNorimichi Akiyama, Masato Karayama, Naoki Inui, et al.Journal of Cancer Research and Clinical Oncology|July 14, 2022
Serum immune modulators associated with immune-related toxicities and efficacy of atezolizumab in patients with non-small cell lung cancerYusuke Inoue, Naoki Inui, Masato Karayama, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 15, 2020
Assessment of Immune-Related Interstitial Lung Disease in Patients With NSCLC Treated with Immune Checkpoint Inhibitors: A Multicenter Prospective StudyYuzo Suzuki, Masato Karayama, Tomohiro Uto, et al.Journal for Immunotherapy of Cancer|July 27, 2023
Six-week oral prednisolone therapy for immune-related pneumonitis: a single-arm phase II studyMasato Karayama, Naoki Inui, Yusuke Inoue, et al.Cancer Immunology, Immunotherapy : CII|June 6, 2021
Increased serum cholesterol and long-chain fatty acid levels are associated with the efficacy of nivolumab in patients with non-small cell lung cancerMasato Karayama, Naoki Inui, Yusuke Inoue, et al.Pageof 5